- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
-
- 长期趋势：
已有67家主力机构披露2024-06-30报告期持股数据，持仓量总计1187.17万股，占流通A股33.14%
- 波段诊断：
-
技术面诊股
诊断结果：2.7技术面打败了43%的股票
技术面评分前10的股票
近期的平均成本为25.59元。
平均成本
近期的平均成本为25.59元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"25.59","date":1732181213,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑输行业平均水平。
[{"date":"2024.11.22","stock":"-5.61","trade":null,"ind":"-3.06"},{"date":"2024.11.21","stock":"-1.02","trade":null,"ind":"0.07"},{"date":"2024.11.20","stock":"1.81","trade":null,"ind":"0.66"},{"date":"2024.11.19","stock":"4.12","trade":null,"ind":"0.67"},{"date":"2024.11.18","stock":"-2.04","trade":null,"ind":"-0.21"},{"date":"2024.11.15","stock":"-1.70","trade":null,"ind":"-1.45"},{"date":"2024.11.14","stock":"-3.17","trade":null,"ind":"-1.73"},{"date":"2024.11.13","stock":"0.26","trade":null,"ind":"0.51"},{"date":"2024.11.12","stock":"-2.55","trade":null,"ind":"-1.39"},{"date":"2024.11.11","stock":"4.30","trade":null,"ind":"0.51"},{"date":"2024.11.08","stock":"1.70","trade":null,"ind":"-0.53"},{"date":"2024.11.07","stock":"2.78","trade":null,"ind":"2.57"},{"date":"2024.11.06","stock":"-0.94","trade":null,"ind":"-0.09"},{"date":"2024.11.05","stock":"1.72","trade":null,"ind":"2.32"},{"date":"2024.11.04","stock":"1.18","trade":null,"ind":"1.17"},{"date":"2024.11.01","stock":"-3.93","trade":null,"ind":"-0.24"},{"date":"2024.10.31","stock":"0.75","trade":null,"ind":"0.42"},{"date":"2024.10.30","stock":"-4.74","trade":null,"ind":"-0.61"},{"date":"2024.10.29","stock":"0.49","trade":null,"ind":"-1.08"},{"date":"2024.10.28","stock":"6.56","trade":null,"ind":"0.68"},{"date":"2024.10.25","stock":"2.46","trade":null,"ind":"0.59"}]
麦澜德,上证指数,医疗器械指数
压力支撑
该股压力位为25.35元，支撑位为24.40元。
[{"text":"\u538b\u529b\u4f4d","value":"25.35","date":1732204800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"24.40","date":1732204800,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.0资金面打败了79%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月22日 17:54
| 机构今日流向(万元) | -2656.76 | 机构5日流向(万元) | -2575.39 |
| 机构10日流向(万元) | -7329.81 | 机构20日流向(万元) | -12778.38 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量减少651.69万股，其中基金净增仓3家，主力净减仓16家，暂未发现中长期投资价值。
截止2024-06-30，共67家主力机构（基金63家，券商集合理财1家，一般法人3家），持仓量总计1187.17万股，占流通A股33.14%
其中，基金持仓与2023-12-31相比：
增仓：11家 ，增持 52.88万股
减仓：8家 ，减持 46.24万股
新出现在主力名单中：40家 ，持有129.71万股
从主力名单中消失：56家 ，原持有788.04万股
其中，基金持仓与2023-12-31相比：
增仓：11家 ，增持 52.88万股
减仓：8家 ，减持 46.24万股
新出现在主力名单中：40家 ，持有129.71万股
从主力名单中消失：56家 ，原持有788.04万股
消息面诊股
诊断结果：5.7消息面打败了83%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 渤海汇金新动能主题混合重仓股麦澜德跌5.61%
2024-11-22 - 麦澜德：11月20日获融资买入555.01万元，占
2024-11-21 - 麦澜德：11月19日获融资买入349.64万元，占
2024-11-20 - 券商观点|医药行业周报：政策边际改善信号显著，医药
2024-11-18 - 麦澜德：公司运动康复产品线在售的诊疗系统中应用了手
2024-11-15 - 麦澜德获27家机构调研：我们会沿用麦澜德在盆底诊疗
2024-11-14 - 11月13日基金调研瞄准这些公司
2024-11-14 - 麦澜德：11月13日获融资买入346.70万元，占
2024-11-14 - 麦澜德：11月12日获融资买入476.60万元
2024-11-13 - 麦澜德：11月11日获融资买入856.48万元，占
2024-11-12
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2024-10-29 |
| 一般消息 | 高管变动 | 因工作调整原因 | 2024-10-14 |
| 利好 | 分红转增 | 10派4.00元(含税) | 2024-08-22 |
| 一般消息 | 募资投向 | 2024-08-21 | |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 一般消息 | 募资投向 | 公司购买资产 | 2024-05-31 |
| 一般消息 | 重大事项 | 关联交易 | 2024-05-31 |
| 利好 | 分红转增 | 10派6元(含税) | 2024-04-26 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-26 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2023-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了11%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2024.11.22","price":"-3.06","value":null},{"date":"2024.11.21","price":"0.07","value":null},{"date":"2024.11.20","price":"0.66","value":null},{"date":"2024.11.19","price":"0.67","value":null},{"date":"2024.11.18","price":"-0.21","value":null},{"date":"2024.11.15","price":"-1.45","value":null},{"date":"2024.11.14","price":"-1.73","value":null},{"date":"2024.11.13","price":"0.51","value":null},{"date":"2024.11.12","price":"-1.39","value":null},{"date":"2024.11.11","price":"0.51","value":null},{"date":"2024.11.08","price":"-0.53","value":null},{"date":"2024.11.07","price":"2.57","value":null},{"date":"2024.11.06","price":"-0.09","value":null},{"date":"2024.11.05","price":"2.32","value":null},{"date":"2024.11.04","price":"1.17","value":null},{"date":"2024.11.01","price":"-0.24","value":null},{"date":"2024.10.31","price":"0.42","value":null},{"date":"2024.10.30","price":"-0.61","value":null},{"date":"2024.10.29","price":"-1.08","value":null},{"date":"2024.10.28","price":"0.68","value":null},{"date":"2024.10.25","price":"0.59","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 浩欧博 | 405.35% | 11.37% | 5.0分 |
| 2 | 热景生物 | 49.74% | 43.37% | 4.5分 |
| 3 | 东方海洋 | 25.00% | 9.32% | 3.2分 |
| 4 | 仁度生物 | 20.44% | -3.87% | 4.2分 |
| 5 | 国发股份 | 18.59% | 3.28% | 4.0分 |
| 6 | 奥美医疗 | 18.31% | 21.01% | 4.3分 |
| 8 | 东星医疗 | 16.21% | 4.84% | 4.3分 |
| 10 | 采纳股份 | 14.77% | 7.67% | 3.7分 |
| 12 | 中红医疗 | 11.25% | 11.16% | 4.1分 |
| 14 | 赛科希德 | 9.59% | -0.04% | 4.9分 |
| 16 | 凯利泰 | 8.04% | -0.17% | 4.2分 |
| 18 | 理邦仪器 | 6.10% | 10.22% | 4.7分 |
| 20 | 天智航 | 5.05% | -0.39% | 4.2分 |
| 22 | 康德莱 | 4.78% | -1.32% | 4.6分 |
| 24 | 康拓医疗 | 3.86% | -1.23% | 4.9分 |
| 26 | 尚荣医疗 | 3.53% | 1.57% | 4.3分 |
| 28 | 港通医疗 | 3.17% | 1.15% | 4.1分 |
| 30 | 博拓生物 | 2.55% | 2.10% | 4.6分 |
| 32 | 黄山胶囊 | 2.42% | -0.63% | 3.8分 |
| 34 | 凯普生物 | 2.35% | 4.81% | 3.5分 |
| 36 | 伟思医疗 | 2.27% | -4.89% | 4.3分 |
| 38 | 明德生物 | 1.82% | 0.80% | 3.9分 |
| 40 | 迈普医学 | 1.30% | -3.41% | 4.2分 |
| 42 | 九安医疗 | 1.06% | -1.03% | 4.4分 |
| 44 | 鱼跃医疗 | 0.77% | -3.83% | 4.6分 |
| 46 | 海泰新光 | 0.42% | -2.25% | 4.4分 |
| 48 | 维力医疗 | 0.23% | -2.03% | 4.9分 |
| 50 | 科美诊断 | 0.00% | -1.83% | 4.5分 |
| 52 | 三鑫医疗 | -0.25% | -0.75% | 4.7分 |
| 54 | 安图生物 | -1.12% | -3.32% | 4.8分 |
| 56 | 安杰思 | -1.35% | -1.21% | 4.7分 |
| 58 | 南微医学 | -1.85% | -3.64% | 4.6分 |
| 60 | 振德医疗 | -2.04% | -2.50% | 4.2分 |
| 62 | 九强生物 | -2.17% | -3.31% | 3.6分 |
| 64 | 易瑞生物 | -2.42% | -1.28% | 3.8分 |
| 66 | 迈克生物 | -2.54% | -2.54% | 3.6分 |
| 68 | 天臣医疗 | -2.89% | -1.86% | 4.5分 |
| 70 | 奥精医疗 | -3.21% | -1.43% | 3.6分 |
| 72 | 圣湘生物 | -3.48% | -0.27% | 4.2分 |
| 74 | 艾德生物 | -3.99% | -1.70% | 4.1分 |
| 76 | 硕世生物 | -4.06% | -6.09% | 3.6分 |
| 78 | 东方生物 | -4.88% | 3.01% | 3.9分 |
| 80 | 新华医疗 | -5.12% | -3.33% | 4.4分 |
| 82 | 欧普康视 | -5.35% | -5.60% | 3.9分 |
| 84 | 乐普医疗 | -5.48% | -3.18% | 3.8分 |
| 86 | 华兰股份 | -5.62% | -4.22% | 3.6分 |
| 88 | 英诺特 | -5.78% | -2.13% | 4.8分 |
| 90 | 迪瑞医疗 | -5.96% | -4.29% | 3.9分 |
| 92 | 万孚生物 | -6.14% | -2.61% | 3.8分 |
| 94 | 春立医疗 | -6.34% | -4.02% | 4.2分 |
| 96 | 东富龙 | -6.90% | -4.71% | 3.7分 |
| 98 | 健帆生物 | -7.03% | -4.54% | 4.2分 |
| 100 | 正海生物 | -7.45% | -5.43% | 3.6分 |
| 102 | 惠泰医疗 | -8.22% | 3.60% | 5.4分 |
| 104 | 华大智造 | -8.85% | -0.75% | 3.9分 |
| 106 | 怡和嘉业 | -10.19% | -2.67% | 3.8分 |
| 108 | 爱迪特 | -10.60% | -5.35% | 3.8分 |
| 110 | 威高骨科 | -10.81% | -5.33% | 4.4分 |
| 112 | 山东药玻 | -11.25% | -3.98% | 4.6分 |
| 114 | 亚辉龙 | -11.90% | -4.43% | 4.5分 |
| 116 | 新产业 | -12.48% | -8.72% | 3.8分 |
| 118 | 爱博医疗 | -13.45% | -8.70% | 4.3分 |
| 120 | 美好医疗 | -14.44% | -4.40% | 3.7分 |
| 122 | 康为世纪 | -16.90% | -5.00% | 3.2分 |
| 124 | - | -57.89% | -14.16% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 41/246 ， 20/246。
[{"date":"2024-09-30","value":"7.24","vol":"4.75"},{"date":"2024-06-30","value":"5.40","vol":"3.52"},{"date":"2024-03-31","value":"2.67","vol":"1.68"},{"date":"2023-12-31","value":"6.66","vol":"12.42"},{"date":"2023-09-30","value":"6.24","vol":"5.68"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.24 | 5.40 | 2.67 | 6.66 | 6.24 |
| 行业(%) | 4.75 | 3.52 | 1.68 | 12.42 | 5.68 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"72.35","vol":"53.32"},{"date":"2024-06-30","value":"73.00","vol":"53.55"},{"date":"2024-03-31","value":"74.05","vol":"53.24"},{"date":"2023-12-31","value":"71.11","vol":"53.43"},{"date":"2023-09-30","value":"70.54","vol":"53.80"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
72.35 | 73.00 | 74.05 | 71.11 | 70.54 |
| 行业(%) | 53.32 | 53.55 | 53.24 | 53.43 | 53.80 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 30/246 ， 38/246。
[{"date":"2024-09-30","value":"13.81","vol":"1.30"},{"date":"2024-06-30","value":"11.73","vol":"0.82"},{"date":"2024-03-31","value":"-4.39","vol":"-0.80"},{"date":"2023-12-31","value":"-9.57","vol":"-6.80"},{"date":"2023-09-30","value":"-2.64","vol":"-5.88"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
13.81 | 11.73 | -4.39 | -9.57 | -2.64 |
| 行业(%) | 1.30 | 0.82 | -0.80 | -6.80 | -5.88 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"13.37","vol":"-19.51"},{"date":"2024-06-30","value":"23.39","vol":"10.41"},{"date":"2024-03-31","value":"12.04","vol":"-14.99"},{"date":"2023-12-31","value":"-26.19","vol":"-23.60"},{"date":"2023-09-30","value":"-13.62","vol":"-0.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
13.37 | 23.39 | 12.04 | -26.19 | -13.62 |
| 行业(%) | -19.51 | 10.41 | -14.99 | -23.60 | -0.28 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 77/246 ， 52/246。
[{"date":"2024-09-30","value":"0.22","vol":"0.26"},{"date":"2024-06-30","value":"0.15","vol":"0.18"},{"date":"2024-03-31","value":"0.07","vol":"0.09"},{"date":"2023-12-31","value":"0.22","vol":"0.37"},{"date":"2023-09-30","value":"0.19","vol":"0.27"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.22 | 0.15 | 0.07 | 0.22 | 0.19 |
| 行业(次) | 0.26 | 0.18 | 0.09 | 0.37 | 0.27 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.59","vol":"1.70"},{"date":"2024-06-30","value":"1.14","vol":"1.14"},{"date":"2024-03-31","value":"0.51","vol":"0.55"},{"date":"2023-12-31","value":"1.59","vol":"2.30"},{"date":"2023-09-30","value":"1.45","vol":"1.61"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.59 | 1.14 | 0.51 | 1.59 | 1.45 |
| 行业(次) | 1.70 | 1.14 | 0.55 | 2.30 | 1.61 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"10.05","vol":"15.39"},{"date":"2024-06-30","value":"33.88","vol":"12.54"},{"date":"2024-03-31","value":"3.89","vol":"2.18"},{"date":"2023-12-31","value":"119.48","vol":"38.60"},{"date":"2023-09-30","value":"25.18","vol":"18.30"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 10.05 | 33.88 | 3.89 | 119.48 | 25.18 |
| 行业 | 15.39 | 12.54 | 2.18 | 38.60 | 18.30 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"3.79","vol":"2.34"},{"date":"2024-03-31","value":"","vol":"0.07"},{"date":"2023-12-31","value":"3.73","vol":"2.90"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 3.79 | - | 3.73 | - |
| 行业 | 0.00 | 2.34 | 0.07 | 2.90 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 92/246 ， 100/246。
[{"date":"2024-09-30","value":"8.04","vol":"5.99"},{"date":"2024-06-30","value":"9.39","vol":"6.01"},{"date":"2024-03-31","value":"9.04","vol":"6.60"},{"date":"2023-12-31","value":"8.80","vol":"5.84"},{"date":"2023-09-30","value":"15.50","vol":"6.82"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
8.04 | 9.39 | 9.04 | 8.80 | 15.50 |
| 行业 | 5.99 | 6.01 | 6.60 | 5.84 | 6.82 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"7.43","vol":"4.83"},{"date":"2024-06-30","value":"8.80","vol":"4.95"},{"date":"2024-03-31","value":"8.53","vol":"5.51"},{"date":"2023-12-31","value":"8.33","vol":"4.84"},{"date":"2023-09-30","value":"14.58","vol":"5.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
7.43 | 8.80 | 8.53 | 8.33 | 14.58 |
| 行业 | 4.83 | 4.95 | 5.51 | 4.84 | 5.72 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 91/246 ， 88/246。
[{"date":"2024-09-30","value":"11.05","vol":"21.18"},{"date":"2024-06-30","value":"10.19","vol":"21.17"},{"date":"2024-03-31","value":"9.55","vol":"20.66"},{"date":"2023-12-31","value":"10.34","vol":"21.24"},{"date":"2023-09-30","value":"6.95","vol":"21.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
11.05 | 10.19 | 9.55 | 10.34 | 6.95 |
| 行业(%) | 21.18 | 21.17 | 20.66 | 21.24 | 21.28 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.13","vol":"0.38"},{"date":"2024-06-30","value":"0.12","vol":"0.37"},{"date":"2024-03-31","value":"0.11","vol":"0.36"},{"date":"2023-12-31","value":"0.12","vol":"0.37"},{"date":"2023-09-30","value":"0.08","vol":"0.36"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.13 | 0.12 | 0.11 | 0.12 | 0.08 |
| 行业(%) | 0.38 | 0.37 | 0.36 | 0.37 | 0.36 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华安证券 | 2024-10-31 | 买入 | 买入 |
| 东方财富证券 | 2024-10-29 | 增持 | 增持 |
| 浙商证券 | 2024-08-22 | 增持 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"1.22","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"1.18","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.22","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.90","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.29","blueLineValue":"1.29","type":"YC"}]